Maia G. Clare

Maia G. Clare

Auto-generated profile, based on publicly available information

Maia G. Clare

Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2025 in Cancer Discovery
Verified
Journal Article
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
In patients with non–small cell lung cancer (NSCLC), the relationship between tumor metabolism and clinical outcomes is unknown. Here, 13C-labeled nutrients were intraoperatively infused into more than 90 patients with surgically resectable pulmonary lesions, and metabolic properties of resected tumors were correlated with survival. In NSCLCs infused with 13C-glucose, high 13C enrichment in tricarboxylic acid (TCA) cycle intermediates conferred a HR of 3.8 for early death, typically with metastasis. To test whether these features reflect requirements for metastasis, we generated patient-derived xenografts that spontaneously metastasize to multiple organs. Treatment with an electron transport chain (ETC) inhibitor reduced glucose-derived TCA cycle labeling but did not suppress subcutaneous tumor growth. However, ETC blockade reduced the abundance of circulating cancer cells and suppressed xenograft metastatic burden in distant organs. Our data demonstrate that isotope labeling can identify metabolic properties associated with metastasis in patients and that blocking the ETC suppresses metastasis in mice. Significance: Intraoperative 13C-glucose infusions in patients with NSCLC show that tumors with high labeling of TCA cycle intermediates progress rapidly, resulting in metastasis and early death. Blocking this pathway suppresses metastasis of human NSCLC cells in mice.

1 September 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DCD. Alejandro Canaria
D. Alejandro Canaria
BYBingyu Yan
Bingyu Yan
MCMaia G. Clare
Maia G. Clare
ZZZonghao Zhang
Zonghao Zhang
GTGrace A Taylor
Grace A Taylor
MOMatthew R Olson
Matthew R Olson
IL-9–producing Th cells, termed Th9 cells, contribute to immunity against parasites and cancers but have detrimental roles in allergic disease and colitis. Th9 cells differentiate in response to IL-4 and TGF-β, but these signals are insufficient to drive Th9 differentiation in the absence of IL-2. IL-2–induced STAT5 activation is required for chromatin accessibility within Il9 enhancer and promoter regions and directly transactivates the Il9 locus. STAT5 also suppresses gene expression during Th9 cell development, but these roles are less well defined. In this study, we demonstrate that human allergy-associated Th9 cells exhibited a signature of STAT5-mediated gene repression that is associated with the silencing of a Th17-like transcriptional signature. In murine Th9 cell differentiation, blockade of IL-2/STAT5 signaling induced the expression of IL-17 and the Th17-associated transcription factor Rorγt. However, IL-2–deprived Th9 cells did not exhibit a significant Th17- or STAT3-associated transcriptional signature. Consistent with these observations, differentiation of IL-17–producing cells under these conditions was STAT3-independent but did require Rorγt and BATF. Furthermore, ectopic expression of Rorγt and BATF partially rescued IL-17 production in STAT3-deficient Th17 cells, highlighting the importance of these factors in this process. Although STAT3 was not required for the differentiation of IL-17–producing cells under IL-2–deprived Th9 conditions, their prolonged survival was STAT3-dependent, potentially explaining why STAT3-independent IL-17 production is not commonly observed in vivo. Together, our data suggest that IL-2/STAT5 signaling plays an important role in controlling the balance of a Th9 versus a Th17-like differentiation program in vitro and in allergic disease. Key Points Human Th9 cells exhibit a STAT5-mediated gene suppression signature. IL-2/STAT5 suppresses a STAT3-independent Th17-like phenotype in Th9 cells. IL-17 production by IL-2–deprived Th9 cells requires Rorγt and BATF.

17 June 2026
Verified
Other
Open access
PDF file
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 2). Epithelial and myeloid cell contributions to gene expression and 13C labeling features.

17 June 2026
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 3). Overall and recurrence-free survival summary.

17 June 2026
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
In patients with non–small cell lung cancer (NSCLC), the relationship between tumor metabolism and clinical outcomes is unknown. Here, 13C-labeled nutrients were intraoperatively infused into more than 90 patients with surgically resectable pulmonary lesions, and metabolic properties of resected tumors were correlated with survival. In NSCLCs infused with 13C-glucose, high 13C enrichment in tricarboxylic acid (TCA) cycle intermediates conferred a HR of 3.8 for early death, typically with metastasis. To test whether these features reflect requirements for metastasis, we generated patient-derived xenografts that spontaneously metastasize to multiple organs. Treatment with an electron transport chain (ETC) inhibitor reduced glucose-derived TCA cycle labeling but did not suppress subcutaneous tumor growth. However, ETC blockade reduced the abundance of circulating cancer cells and suppressed xenograft metastatic burden in distant organs. Our data demonstrate that isotope labeling can identify metabolic properties associated with metastasis in patients and that blocking the ETC suppresses metastasis in mice.Significance:Intraoperative 13C-glucose infusions in patients with NSCLC show that tumors with high labeling of TCA cycle intermediates progress rapidly, resulting in metastasis and early death. Blocking this pathway suppresses metastasis of human NSCLC cells in mice.

2 April 2025
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 2). Transcriptomic data for NSCLC and adjacent lung tissue fragments.